"Within 42 days after using the Janssen vaccine, the risk of developing Guillain-Barré syndrome increases," RIA Novosti quotes the agency's report.

In this rare condition, the immune system attacks the nerve cells.

Earlier, the United States delivered almost 1.5 million doses of Johnson & Johnson coronavirus vaccine to Afghanistan out of more than 3 million promised.